Prefrontal cortex-specific Dcc deletion induces schizophrenia-related behavioral phenotypes and fail to be rescued by olanzapine treatment.
暂无分享,去创建一个
Yunxi Liu | Shengying Qin | Weining Zhang | Jia Wang | Jin-jun Qian | Tingkai Sun | Qijie Cong | Rongsen Zeng | Siyu Xi | Jing Sun | Jing Gao
[1] J. Qian,et al. Cyclophilin D-mediated angiotensin II-induced NADPH oxidase 4 activation in endothelial mitochondrial dysfunction that can be rescued by gallic acid. , 2022, European journal of pharmacology.
[2] Lin He,et al. miR143-3p–Mediated NRG-1–Dependent Mitochondrial Dysfunction Contributes to Olanzapine Resistance in Refractory Schizophrenia , 2022, Biological Psychiatry.
[3] R. Brownstone,et al. Heterozygous Dcc Mutant Mice Have a Subtle Locomotor Phenotype , 2022, eNeuro.
[4] I. Sommer,et al. The dual hit hypothesis of schizophrenia: Evidence from animal models , 2021, Neuroscience & Biobehavioral Reviews.
[5] Feng Liu,et al. Increased Homotopic Connectivity in the Prefrontal Cortex Modulated by Olanzapine Predicts Therapeutic Efficacy in Patients with Schizophrenia , 2021, Neural plasticity.
[6] Z. Yao,et al. Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization , 2021, Nature Communications.
[7] Kohji Sato. Why is prepulse inhibition disrupted in schizophrenia? , 2020, Medical hypotheses.
[8] Meina Guo,et al. Adult conditional knockout of PGC-1α in GABAergic neurons causes exaggerated startle reactivity, impaired short-term habituation and hyperactivity , 2020, Brain Research Bulletin.
[9] Shao J Liu,et al. No DCX-positive neurogenesis in the cerebral cortex of the adult primate , 2020, Neural regeneration research.
[10] Meiyu Wu,et al. A pilot study on searching for peri-nuclear NeuN-positive cells , 2020, PeerJ.
[11] E. S. Ruthazer,et al. Pre- and post-synaptic roles for DCC in memory consolidation in the adult mouse hippocampus , 2019, Molecular Brain.
[12] F. Bustos,et al. PSD95 regulates morphological development of adult-born granule neurons in the mouse hippocampus , 2019, Journal of Chemical Neuroanatomy.
[13] H. Ahsan,et al. Asiatic Acid Protects Dopaminergic Neurons from Neuroinflammation by Suppressing Mitochondrial ROS Production , 2019, Biomolecules & therapeutics.
[14] P. McGuire,et al. Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis , 2019, JAMA psychiatry.
[15] Qiu-Yun Chen,et al. Smart mitochondrial‐targeted cancer therapy: Subcellular distribution, selective TrxR2 inhibition accompany with declined antioxidant capacity , 2019, International journal of pharmaceutics.
[16] Hunna J. Watson,et al. Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders , 2019, bioRxiv.
[17] E. S. Ruthazer,et al. Activity-Dependent Netrin-1 Secretion Drives Synaptic Insertion of GluA1-Containing AMPA Receptors in the Hippocampus. , 2018, Cell reports.
[18] G. Breen,et al. Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort , 2018, Translational Psychiatry.
[19] R. Kahn,et al. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE) , 2018, Molecular Psychiatry.
[20] Anders M. Dale,et al. Genetic Overlap Between Schizophrenia and Volumes of Hippocampus, Putamen, and Intracranial Volume Indicates Shared Molecular Genetic Mechanisms , 2018, Schizophrenia bulletin.
[21] Qiu-Yun Chen,et al. Mitochondrial dysfunction is responsible for fatty acid synthase inhibition-induced apoptosis in breast cancer cells by PdpaMn. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[22] Wenjun Gao,et al. PSD95: A synaptic protein implicated in schizophrenia or autism? , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[23] Chi Ma,et al. Netrin-1 promotes glioma growth by activating NF-κB via UNC5A , 2017, Scientific Reports.
[24] A. Tanskanen,et al. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia , 2017, JAMA psychiatry.
[25] Jing Gao,et al. Desensitizing Mitochondrial Permeability Transition by ERK-Cyclophilin D Axis Contributes to the Neuroprotective Effect of Gallic Acid against Cerebral Ischemia/Reperfusion Injury , 2017, Front. Pharmacol..
[26] E. Nestler,et al. DCC Confers Susceptibility to Depression-like Behaviors in Humans and Mice and Is Regulated by miR-218 , 2017, Biological Psychiatry.
[27] A. Vita,et al. Schizophrenia , 2016, The Lancet.
[28] H. Lei,et al. NMDA receptor antagonism by repetitive MK801 administration induces schizophrenia-like structural changes in the rat brain as revealed by voxel-based morphometry and diffusion tensor imaging , 2016, Neuroscience.
[29] F. Turkheimer,et al. Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive. , 2016, Schizophrenia bulletin.
[30] Peng Yan,et al. An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia , 2016, Journal of Molecular Neuroscience.
[31] M. Buckwalter,et al. Glial Fibrillary Acidic Protein-Expressing Glia in the Mouse Lung , 2015, ASN neuro.
[32] J. Sato,et al. Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia , 2013, Schizophrenia Research.
[33] E. S. Ruthazer,et al. DCC expression by neurons regulates synaptic plasticity in the adult brain. , 2013, Cell reports.
[34] Daniel L. Koller,et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction , 2012, Molecular Psychiatry.
[35] D. Rao,et al. siRNA vs. shRNA: similarities and differences. , 2009, Advanced drug delivery reviews.
[36] H. Gunduz-Bruce,et al. The acute effects of NMDA antagonism: From the rodent to the human brain , 2009, Brain Research Reviews.
[37] Ferran Sanz,et al. Multi‐Receptor Binding Profile of Clozapine and Olanzapine: A Structural Study Based on the New β2 Adrenergic Receptor Template , 2008, ChemMedChem.
[38] P. Roussos,et al. Improvement of Prepulse Inhibition and Executive Function by the COMT Inhibitor Tolcapone Depends on COMT Val158Met Polymorphism , 2008, Neuropsychopharmacology.
[39] Yudong D. He,et al. Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice , 2006, Nucleic acids research.
[40] Kyonsoo Hong,et al. Activation of FAK and Src are receptor-proximal events required for netrin signaling , 2004, Nature Neuroscience.
[41] M. Sheng,et al. Postsynaptic Signaling and Plasticity Mechanisms , 2002, Science.
[42] O. Wolkowitz,et al. Benzodiazepines in Schizophrenia: Prefrontal Cortex Atrophy Predicts Clinical Response to Alprazolam Augmentation , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[43] D. Javitt,et al. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. , 2000, Archives of general psychiatry.
[44] R. Malinow,et al. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. , 2000, Science.
[45] C. Stephenson,et al. Psychopharmacology of olanzapine , 1999, British Journal of Psychiatry.
[46] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[47] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[48] Qiang Xu,et al. Andrographolide alleviates parkinsonism in MPTP-PD mice via targeting DRP1-mediated mitochondrial fission. , 2019, British journal of pharmacology.
[49] Qiang Xu,et al. Andrographolide sulfonate improves Alzheimer-associated phenotypes and mitochondrial dysfunction in APP/PS1 transgenic mice. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[50] W. Honer,et al. Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats. , 2014, The international journal of neuropsychopharmacology.
[51] Jürgen Götz,et al. Primary support cultures of hippocampal and substantia nigra neurons , 2008, Nature Protocols.
[52] Pavel Osten,et al. Stereotaxic gene delivery in the rodent brain , 2007, Nature Protocols.
[53] R. Malenka,et al. AMPA receptor trafficking and synaptic plasticity. , 2002, Annual review of neuroscience.